Herein, we report the case of a 60-year-old man, a smoker with a history of arterial hypertension and diabetes mellitus. After computed tomography (CT) for an episode of hemoptysis, the patient underwent elective thoracic endovascular aortic repair (TEVAR) because of a degenerative aneurysm of the descending thoracic aorta. The area of perianeurysmal pulmonary atelectasis reported on the CT scan was not considered. Three months later, he developed an aortopulmonary fistula without endoleaks. Although TEVAR is a relatively safe procedure, no detail should be overlooked in the preoperative evaluation in order to avoid life-threatening complications. Further, the effectiveness and modality of prolonged antibiotic prophylaxis and/or preoperative respiratory physiotherapy should be assessed in such cases. 
Herein, we report the case of a 60-year-old man, a smoker with a history of arterial hypertension, diabetes mellitus, and recent unspecified retinal vein thrombosis treated with heparin and oral anticoagulants. In the emergency department (ED), following an episode of hemoptysis, the patient underwent thoracic contrast-enhanced multidetector computed tomography (CE-MDCT) revealing ground-glass opacities (GGO) in the left lung parenchyma for hemorrhagic alveolitis, associated with small consolidation areas in the presence of normal blood inflammatory indices (serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count). Further, the CE-MDCT revealed a saccular aneurysm of the left side wall of the descending thoracic aorta with a maximum transverse diameter of 57 mm and atelectasis of the surrounding lung parenchyma compressed by the aneurysm (Fig. 1) . The saccular aneurysm was considered to be of atherosclerotic nature, considering the relatively high incidence of atherosclerotic saccular aneurysms [1] ; the lack of clearly suggestive computed tomography (CT) signs for an infected aneurysm; the absence of fever, interscapular or back pain, or coughing; completely normal inflammatory indices; and no history of high-energy trauma or bladder cancer. Moreover, considering the favorable anatomical location of the aneurysm and the spontaneous cessation of hemoptysis, elective thoracic endovascular aortic repair (TEVAR) was carried out. However, after approximately 3 months, the patient returned to the ED with a new episode of hemoptysis, and therefore underwent multiphase CE-MDCT, which excluded a pulmonary embolism, showing the correct positioning of the endoprosthesis, the total absence of an endoleak, size reduction of the aortic aneurysm sac for thrombus retraction, size reduction of the parenchymal lung atelectasis, the onset of air bubbles in the excluded aneurysmal sac with a linear arrangement of air and an interruption of the aortic wall in the minimum intensity projection reformation, and persistent GGO that explained the new episode of hemoptysis (Fig. 2) . Therefore, the patient was hospitalized again. Since the inflammatory markers were normal and the patient had neither fever nor chest pain in the absence of the CE-MDCT signs of a stent-graft infection, we decided upon nonoperative management, reserving the possibility of open aortic repair if the hemoptysis worsened and pending the performance of positron emission tomography-CT if a stent-graft infection was suspected. Fortunately, after 5 days, CE-MDCT imaging showed a significant reduction of air in the aneurysmal sac and a reduction of the GGO along with lung consolidation. Therefore, the patient was discharged with home care (Fig. 3) . One week after being discharged from the hospital, the patient returned to our clinic completely asymptomatic and his blood tests confirmed the normality of the inflammatory markers. After 1 month, a follow-up CT scan confirmed a gradual improvement of the thoracic findings.
Discussion
Aortopulmonary and aortobronchial fistulas (ABPFs) are a rare but feared condition that, favored by the long course of the aorta and due to its elevated intraluminal pressure, may arise as a life-threatening postoperative complication. Although the incidence of ABPFs is reported to be relatively high after open surgery, this complication has also been reported after TEVAR in the literature [2, 3] . TEVAR is known to be a valid alternative to open surgery and is often the first therapeutic solution for the treatment of thoracic aortic disease, particularly in patients in whom the presence of a comorbidity contraindicates traditional surgery [4] [5] [6] . However, even though TEVAR is relatively safe, several complications related to this procedure have been reported in the literature. In particular, ABPFs have a relatively low incidence, ranging from 0.56% to 0.8% [2, 3] , but an infection of the stent graft is feared, often requiring repair with open surgery [4, 5] . In ABPFs, hemoptysis is often the only symptom and depends on the fistula entity. CE-MDCT can be used to identify changes in the adjacent lung as consolidation or rarely, the flooding of the intravenous contrast medium into the lung tissue or airways. Sometimes, intragraft or perigraft air is an indirect sign that may be the only sign of a fistula. Leukocytosis, fever, and chest pain are nonspecific clinical findings in the case of a serious graft infection. In such cases, CE-MDCT can show aortic wall thickening, perigraft soft tissue or fluid collection, pseudo-aneurysm, perigraft air or an increasing amount of air on serial imaging examinations, adjacent soft-tissue stranding, abscess formation, and graft thrombosis or expansion [3] . This case shows that even in the overall evaluation before a relatively safe procedure such as TEVAR, no MDCT detail can be overlooked, even a minor detail such as the limited area of atelectasis. In fact, longstanding atelectasis may indicate adherence to the aneurysmal aortic wall that is already lacking elasticity. Furthermore, chronic pulsatile compression of a progressively degenerative aneurysm that expands into the lung parenchyma and the airways could cause a local inflammatory response with a further formation of adhesions. Despite the excellent positioning of the endoprosthesis and the total absence of endoleaks, in the considered case, the reduction of the aneurysmal sac size that comes from thrombus retraction might be associated with better expansion of the periaortic lung parenchyma (no longer compressed), and cause traction on the wall of the aneurysmal sac, thereby causing an aortopulmonary fistula. Furthermore, vigorous coughing due to hemoptysis can increase the amount of air, further emphasizing the interruption of the aortic wall and air embolism into the excluded aneurysmal sac [7] . Fortunately, the patient never presented with leukocytosis, fever, or chest pain; hemoptysis, although important, was limited, considering the absence of an endoleak, and required only prudent admission to a highly specialized department.
Some authors have argued that many endoprostheses are placed off-label and that some indications of TEVAR are often bold and not adequately proven [2, 5] . However, this case shows that even when all the indications stated in the international guidelines are observed [8] , TEVAR, which is relatively easy a favorable position and extent, with a regular diameter and optimal length of the healthy proximal and distal landing zones, may be complicated by dangerous events, such as an ABPF, if small MDCT details are underestimated in the preoperative assessment. Furthermore, the present case supports the viewpoint of other authors who have recommended a multidisciplinary approach for determining the type of treatment for thoracic aortic disease depending on the functional anatomy, pathology, and comorbidity of the case being treated [8] . Further multicenter studies are needed to encourage the development of additional preoperative risk stratification tools that − 290 − must take into account the smaller MDCT details that are often not considered in a pre-TEVAR evaluation, but might still be responsible for undesirable postoperative complications requiring conversion to open repair. Finally, although encouraging studies on respiratory physiotherapy before cardiothoracic and abdominal surgery have been reported in the literature [9] [10] [11] , currently, the role of this procedure, which is generally associated with prolonged antibiotic prophylaxis, has never been considered when it is performed before endovascular procedures. Therefore, respiratory physiotherapy, a safe and relatively inexpensive practice, could be introduced before elective TEVAR procedures with associated perianeurysmal pulmonary atelectasis to avoid potentially catastrophic postoperative complications, such as an ABPF or a peri-stent-graft infection, even in the absence of endoleaks.
